1. Home
  2. QNCX vs LICN Comparison

QNCX vs LICN Comparison

Compare QNCX & LICN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • QNCX
  • LICN
  • Stock Information
  • Founded
  • QNCX 2012
  • LICN 2004
  • Country
  • QNCX United States
  • LICN China
  • Employees
  • QNCX N/A
  • LICN N/A
  • Industry
  • QNCX Biotechnology: Biological Products (No Diagnostic Substances)
  • LICN
  • Sector
  • QNCX Health Care
  • LICN
  • Exchange
  • QNCX Nasdaq
  • LICN Nasdaq
  • Market Cap
  • QNCX 70.4M
  • LICN 8.7M
  • IPO Year
  • QNCX 2019
  • LICN 2023
  • Fundamental
  • Price
  • QNCX $1.60
  • LICN $0.07
  • Analyst Decision
  • QNCX Strong Buy
  • LICN
  • Analyst Count
  • QNCX 4
  • LICN 0
  • Target Price
  • QNCX $9.50
  • LICN N/A
  • AVG Volume (30 Days)
  • QNCX 130.8K
  • LICN 11.9M
  • Earning Date
  • QNCX 11-13-2024
  • LICN 12-31-2024
  • Dividend Yield
  • QNCX N/A
  • LICN N/A
  • EPS Growth
  • QNCX N/A
  • LICN 36.90
  • EPS
  • QNCX N/A
  • LICN 0.28
  • Revenue
  • QNCX N/A
  • LICN $41,929,000.00
  • Revenue This Year
  • QNCX N/A
  • LICN N/A
  • Revenue Next Year
  • QNCX N/A
  • LICN N/A
  • P/E Ratio
  • QNCX N/A
  • LICN $0.29
  • Revenue Growth
  • QNCX N/A
  • LICN 24.86
  • 52 Week Low
  • QNCX $0.51
  • LICN $0.06
  • 52 Week High
  • QNCX $2.45
  • LICN $2.44
  • Technical
  • Relative Strength Index (RSI)
  • QNCX 43.92
  • LICN 22.59
  • Support Level
  • QNCX $1.49
  • LICN $0.06
  • Resistance Level
  • QNCX $1.69
  • LICN $0.08
  • Average True Range (ATR)
  • QNCX 0.14
  • LICN 0.02
  • MACD
  • QNCX 0.00
  • LICN 0.03
  • Stochastic Oscillator
  • QNCX 46.15
  • LICN 12.06

About QNCX Quince Therapeutics Inc.

Quince Therapeutics Inc is preclinical stage biopharmaceutical company focused on advancing innovative precision therapeutics for debilitating and rare diseases. The company discovered a broad bone-targeting drug platform designed to precisely deliver small molecules, peptides, or large molecules directly to the site of bone fracture and disease to promote rapid healing with fewer off-target safety concerns compared to non-targeted therapeutics.

About LICN Lichen China Limited

Lichen China Ltd is a holding company. The company, along with its subsidiaries provides financial and taxation solution services; education support services; and software and maintenance services. The company generates Majority revenue from Financial and taxation solution services.

Share on Social Networks: